120 Capital Management Asset Manager Profile - aVenture Research
120 Capital Management is a global macro investment firm operating worldwide. The company focuses on macro-level economic trends and geopolitical events to inform their investment strategies across various asset classes and markets.
While specific portfolio details are limited, 120 Capital Management has invested in Immunitas Therapeutics, a biotechnology company that has raised $58 million. The firm has participated in at least one Series B funding round, indicating an interest in supporting companies at growth stages. Their global macro approach likely provides portfolio companies with valuable insights into market trends and economic factors affecting their industries.
Portfolio Snapshot
Observed round participation, including acquisitions and grants. Current holdings, investor exits, and write-offs are not established.
